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Abstract
Introduction: Intra‐atrial conduction abnormalities are associated with the development
of atrial fibrillation (AF) and cause morphological changes of the unipolar atrial
electrogram (U‐AEGM). This study examined the impact of different atrial programmed
electrical stimulation (APES) protocols on U‐AEGM morphology to identify the most
optimal APES protocol provoking conduction abnormalities.
Methods: APES techniques (14 protocols) were applied in 30 patients referred for
an electrophysiology study, consisting of fixed rate, extra, and decremental stimuli
at different frequencies. U‐AEGM morphologies including width, amplitude, and
fractionation for patients without (control group) and with a history of AF (AF group)
were examined during APES. In addition, sinus rhythm (SR) U‐AEGMs preceding
different APES protocols were compared to evaluate the morphology stability
over time.
Results: U‐AEGMmorphologies during SR before the APES protocols were comparable
(all P > .396). Atrial refractoriness was longer in the AF group compared to the control
group (298 ± 48 vs 255 ± 33ms; P ≤ .020), but did not differ between AF patients with
and without amiodarone therapy (278 ± 48 vs 311 ± 40ms; P ≥ .126). Compared to
the initial SR morphology, U‐AEGM width, amplitude, and fractionation changed
significantly during the 14 different APES protocols, particularly in the AF group. In
both groups, U‐AEGM changes in morphology were most pronounced during fixed‐rate
stimulation with extra stimuli (8S1‐S2 = 400‐250ms).
Conclusion: APES results in significant changes in U‐AEGM morphology, including
width, amplitude, and fractionation. The impact of APES differed between APES
sequence and between patients with and without AF. These findings suggest
that APES could be useful to identify AF‐related conduction abnormalities in the
individual patient.
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1 | INTRODUCTION
Intra‐atrial conduction abnormalities are the main features of the
electropathological substrate underlying persistence of atrial
fibrillation (AF).1 High‐density epicardial mapping studies have
demonstrated that intra‐atrial conduction abnormalities are
expressed in the morphology of the unipolar atrial electrogram
(U‐AEGM).2‐6 Conduction abnormalities during sinus rhythm (SR)
mainly occur at specific locations or maybe predominantly masked
due to nonuniform anisotropic tissue properties.7,8 Dedicated
electrical stimulation techniques, which have the advantage of
providing a stable and repetitive heart rhythm, may unmask areas of
conduction abnormalities.9‐14 However, which programmed electrical
stimulation technique is most optimal for provoking intra‐atrial
conduction abnormalities is still unknown.15
We hypothesize that different atrial programmed electrical
stimulation techniques (APES) reveal intra‐atrial conduction
abnormalities to a variable degree. The aim of this study is, therefore,
(a) to investigate the impact of various stimulation techniques on the
U‐AEGM morphology of patients without (control group) and with a
history of AF (AF group), and (b) to identify the most optimal APES
sequence to unmask intra‐atrial conduction abnormalities.
2 | METHODS
2.1 | Study population
The study population consisted of patients scheduled for an
electrophysiology study and if applicable ablative therapy. As
programmed electrical stimulation is a part of a normal electro-
physiological study before ablative therapy and standard
techniques and equipment were used, the Erasmus MC medical
ethics committee decided written consent from the participants was
not required (MEC‐2014‐511).
2.2 | Materials
After femoral vein access, a standard diagnostic quadri‐ or
hexapolar catheter (M0045291S0, 6F Explorer 360, 2‐mm band
electrodes, 5‐mm electrode spacing; Boston Scientific Corporation
[BSCI], San Jose, CA, or 401271, 6F Response, 2‐mm band
electrodes, 5‐mm electrode spacing, St. Jude Medical [SJM],
Minnetonka, MN) was positioned in the right atrial auricle (RAA).
A standard diagnostic decapolar catheter (M0047000D0, 6F
Polaris X, 1‐mm band electrodes with 2.5 mm interelectrode
distance; BSCI) was placed clockwise across the right atrial free wall
(RAFW). Catheter positions were confirmed with fluoroscopic
images using left and right anterior oblique views. Figure 1 shows a
schematic representation of the catheter positions during the
electrophysiology study.
2.3 | Signal recording and APES protocols
From each electrode of the decapolar RAFW catheter, unipolar
signals were recorded at 2‐kHz sampling rate by the EP‐WorkMate
Recording System V4.3.2 (SJM, St. Paul, MN), while APES was
performed from the distal electrode pair of the RAA catheter with
an integrated EP‐4 clinical stimulator (EP MedSystems, West
Berlin, NJ). Before recording, stimulation configurations were
tested for atrial capture and thresholds (milliamperes, mA). APES
output was programmed at least 2 mA above a threshold value to
ensure atrial capture.
Signals were filtered with 0.05 to 500 Hz filter and amplified to
1mV/cm. The patient's leg, or the proximal hexapolar catheter
electrode in the inferior caval vein if available, was used as an
indifferent electrode. Einthoven's ECG lead II served as a reference
for the timing of the ventricular activity.
Signals were recorded during SR and during specific APES
protocols at different sequences and frequencies, including fixed‐rate
stimulation without and with extra stimuli and decremental stimu-
lation, as summarized in the left side of Table 1. Between the
subsequent protocols, the APES was interrupted to allow the
recovery of the intrinsic SR. Protocols with longer APES than SR
cycle length (CL) were off course excluded. When atrial refractori-
ness (AR; defined as the failure to excite atrial tissue) was reached or
fusion of the APES U‐AEGM with far‐field R waves (FFRW) occurred,
the specific protocol was repeated once for confirmation.
Each sequence of the APES protocol was exported in binary
format (2 byte integer, 1 μV/least significant bit), converted and im-
ported in custom‐made MATLAB software (MathWorks, Natick, MA)
for further analysis.
F IGURE 1 Anatomy and catheter positions. Schematic picture
of the heart with positions of the stimulation and recording catheters
inserted in the right atrium at the start of the electrophysiological
procedure. The anterior wall has been partially removed to visualize
the inside of the atria. Stimulation was applied from the distal
electrode pair of the stimulation catheter (11), positioned in the
RAA. Recordings were taken from the recording catheter (12)
placed in the RAFW region. CSOS, coronary sinus ostium; IAS,
interatrial septum; IVS, interventricular septum; LA, left atrium;
LAA, left atrial appendage; LPV, left pulmonary veins; LV, left
ventricle; MV, mitral valve; RA, right atrium; RAA, right atrial
appendage; RAFW, right atrial free wall; Rec, recording catheter;
RPV, right pulmonary veins; RV, right ventricular; Stim, stimulation
catheter; TV, tricuspid valve; VCI, inferior caval vein; VCS, superior
caval vein
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2.4 | Description of the U‐AEGM morphology
Widths, amplitudes, and fractionation of SR and APES U‐AEGM were
examined as displayed in the upper panel of Figure 2. The width of
the U‐AEGM (milliseconds, ms) was measured between the first and
the last deviation from the baseline and the amplitude (milliVolts,
mV) between the most positive and negative peak. Fractionation was
defined as the presence of two or more negative deflections, as
previously described.16,17
2.5 | Comparison of U‐AEGM morphologies
between SR and APES
For every patient, U‐AEGM morphologies obtained during SR
before initiation of each different APES protocol were compared
for each individual electrode to assess the stability of the U‐AEGM
morphology over time.
The impact of different APES protocols on U‐AEGM morpholo-
gies was examined by calculating differences between SR and APES
U‐AEGM widths, amplitudes, and fractionation. The U‐AEGM
morphology obtained during SR was compared with the (a) APES
U‐AEGM morphology (S1) during fixed‐rate stimulation, (b) extra
stimuli (S2) U‐AEGM morphology during fixed‐rate stimulation with
extra stimuli, and (c) U‐AEGM morphology of the last captured APES
beat during decremental stimulation.
Changes in U‐AEGM morphology during the specific
APES protocols were evaluated for the entire patient group
as well as for the control group and the AF group separately,
when appropriate. Subsequently, the APES protocols resulting
in the most significant changes in the U‐AEGM morphology
were identified.
2.6 | Statistical analysis
Statistics were performed with Excel 2010 (Microsoft Corpora-
tion, Redmond, WA) and SPSS Statistics 24 (IBM Corporation,
Armonk, NY). Normality was tested using the Shapiro‐Wilk test.
Normally distributed variables were presented by mean ± SD, or
by median (minimum‐maximum) when skewed and compared by
Student t or Mann‐Whitney U test. Numerical data were assessed
TABLE 1 Effectiveness of the various atrial programmed electrical stimulation protocols
Stimulation protocol Usable recordings Not usable recordings due to (n)
No. Maneuver Sequence, ms (n (%)) NA BCL ≤ 600ms ARa FFRWa Induced AF
Baseline SR
1 … 30 (100)
Fixed‐rate stimulation (S1)
2 BCL −50 b 23 (77) 5 2
3 500 29 (97) 1
4 400 29 (97) 1
5 300 27 (90) 1 2
Fixed‐rate stimulation with single extra (8S1‐S2)
6 600‐350 27 (90) 1 1 1
7 600‐300 22 (73) 2 2 4
8 600‐250 11 (37) 4 2 11c 1 1
9 500‐350 29 (97) 1
10 500‐300 24 (80) 1 4 1
11 500‐250 15 (50) 1 12c 1 1
12 400‐350 24 (80) 4 1d 1
13 400‐300 24 (80) 2 3d 1
14 400‐250 15 (50) 2 8 4 1
Decremental stimulation (−50ms decrement)
15 600‐550‐500‐…‐200 27 (90) 2 … … … 1
15 protocols × 30 pts = 450 attempts 356 (79) 28 7 45a 10 4
Note: Left column: details of the applied APES protocols, middle column: total number of recordings that could be used for U‐AEGM analysis for every
APES protocol separately. Right columns: the number of recordings that could not be used due to BCL ≤ 600ms, AR, FFRW, or induced AF.
Abbreviations: AF, atrial fibrillation; AR, atrial refractoriness; BCL, basic cycle length; FFRW, far‐field R wave; NA, not available; SR, sinus rhythm;
U‐AEGM, unipolar atrial electrogram.
aIn case of combined occurrence of AR and FFRW, AR was counted.
bMinimal 550ms.
cIn case of combined occurrence of AR and FFRW, AR was counted (including 2× FFRW).
dIn case of combined occurrence of AR and FFRW, AR was counted (including 1× FFRW).
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by the Wilcoxon signed‐rank test, while variability between and
within groups was analyzed using analysis of variance. Catego-
rical data were expressed as numbers (%) and analyzed using
Pearson χ2 test when appropriate. P < .050 was considered as
statistically significant.
3 | RESULTS
3.1 | Study population
A total of 30 patients (18 male; 50 [12‐80] years) were
included. Patient characteristics are summarized in Table 2.
Before the procedure, 11 patients (37%) had documented AF
episodes. The majority had a normal left ventricular ejection
fraction (LVEF); in four patients, the LVEF was impaired. During
the electrophysiological study, diagnosis of the induced ta-
chyarrhythmia was AF (n = 5), atrial flutter (AFL; n = 2), AFL + AF
(n = 2), atrial tachycardia (AT; n = 4), atrioventricular nodal re‐
entry tachycardia (AVNRT; n = 10), atrioventricular re‐entry ta-
chycardia (AVRT; n = 2), or ventricular tachycardia (n = 1). In four
patients, arrhythmias could not be induced. All patients in whom
AF was induced, had documented AF episodes before the pro-
cedure. None of the patients in whom AVNRT was induced had a
history of AF episodes. AFL, AT, and AVRT was equally induced in
both groups.
F IGURE 2 Analysis of U‐AEGM Morphology. Upper panel:
examples of width (w) and amplitude (A) measurements in
nonfractionated and fractionated U‐AEGMs. The width of the
U‐AEGM is defined as the duration from the first deviation from
the baseline until it returns to the baseline, whereas the amplitude
is the voltage difference between positive and negative peaks. Red
dots mark the negative slopes of the U‐AEGMs. When two or more
negative slopes were present, the U‐AEGM was labeled as
fractionated. See the text for further explanation. Lower panel: (A)
fusion of the U‐AEGM after S2 extra stimulus with the FFRW in
the third electrogram, (B) the arrow indicates AR occurring after
S2 extra stimulus, and (C) U‐AEGM with the low signal‐to‐noise
ratio. Green, blue, and red rectangles in the U‐AEGM tracings
represent, respectively, the windows of stimulation artifact (∏),
the U‐AEGM (A), and the FFRW signal (V). AR, atrial
refractoriness; FFRW, far‐field R waves; U‐AEGM, unipolar
atrial electrogram
TABLE 2 Demographic and clinical data
Characteristics
Total
populationa
(n = 30) AF (11) No AF (19)
Median age at
procedure, y
50.1 (11.7‐80.0) 49.6
(35.5‐80.0)
51.0
(11.7‐71.7)
Male, sex 17 (57) 7 10
CHD 2 (7) … 2
CAD 2 (7) 2 …
TIA/stroke 2 (7) 1 1
Diagnosis of induced tachyarrhythmia
Paroxysmal AF 5 (17) 5 …
AFL 2 (7) 1 1
Paroxysmal
AF + AFL
2 (7) 2 …
AT 4 (13) 2 2
AVNRT 10 (33) … 10
AVRT 2 (7) 1 1
VT 1 (3) … 1
N. I. 4 (13) … 4
Antiarrhythmic drug class
IA 2 (7) 1 1
II 8 (27) 6 2
III 8 (27) 2 6
Including
amiodarone
5b (17) … 5
IV 4 (13) 2 2
Note: Categorical data are presented as n (%). Characteristics
of the study population. The number and percentages are given
for the entire study population. The numbers are also given for
both patient groups separately (patients without and patients
with a history of AF) to visualize similarities and differences.
See text for further explanation.
Abbreviations: AF, atrial fibrillation; AFL, atrial flutter;
AT, atrial tachycardia; AVNRT, atrioventricular nodal reentrant
tachycardia; AVRT, atrioventricular re‐entry tachycardia;
CAD, coronary artery disease; CHD, coronary heart disease;
LVEF, left ventricular ejection fraction; N. I., not inducible;
TIA, transient ischemic attack; VT, ventricular tachycardia.
aOnly patients of which U‐AEGMs are included.
bAll five patients have a history of AF.
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3.2 | Database of U‐AEGMs
Table 1 shows the applicability of each of the different APES pro-
tocols separately. Seventy‐nine percent (n = 356) of the APES
attempts (n = 450) was successfully executed and suitable for
analysis. The remaining protocols (n = 94; 21%) were excluded due to
SR‐CL shorter than the CL of the APES protocol (n = 7), repeated
occurrence of AR (n = 45; including six times in combination
with FFRW), FFRW fusion (n = 10), or accidental induction of AF
(n = 4; two times combined with FFRW fusion).
AR varied from 200 to 390ms (Table 3). AR was significantly
longer in the AF group compared to the control group (298 ± 48 vs
255 ± 33ms; P ≤ .020). There was no difference in AR between the
AF patients with and without amiodarone therapy (278 ± 48 vs
311 ± 40ms; P ≤ .126).
The excluded APES protocols contained 2850 U‐AEGMs. In
addition, 460 individual U‐AEGMs (3.4%) were excluded from
analysis due to poor signal quality. The final U‐AEGM database
consisted of 10 504 U‐AEGMs (SR: 3872 and APES: 6632). Typical
examples of excluded U‐AEGMs are shown in Figure 2B.
3.3 | Temporal stability of U‐AEGMs
Figure 3 shows the boxplots of SR U‐AEGM widths and amplitudes
recorded before each of the different APES protocol, depicted per
electrode for both the control and the AF group separately. As
demonstrated in Table S1, for all recording sites, there were no
significant SR U‐AEGM differences in width (control group P ≥ .396;
AF group P ≥ .818) and amplitude (control group P ≥ .969; AF group
P ≥ .561), indicating stable catheter positions.
3.4 | Impact of fixed‐rate stimulation and extra
stimuli on U‐AEGM morphology
The impact of each of the different APES protocols on Δ width and Δ
amplitude of U‐AEGMs is shown in Figure 4. Changes in both width
and amplitude were most pronounced in the AF group. As demon-
strated in Table S2, fixed‐rate stimulation decreased the U‐AEGM
width significantly for all protocols (P ≤ .022, control vs AF groups;
P = .000). In contrast, during the shortening of the coupling interval of
the extra stimuli, the width increased, but only significantly in pro-
tocol 8 (P ≤ .018, control vs AF groups; P = .000).
The amplitude decreased both for fixed‐rate stimulation
and extra stimuli, and decreased further during shorter coupling
intervals (significant: protocols 8 and 13; P ≤ .043, control vs AF
groups; P ≤ .007).
Figure 5 shows the influence of APES on fractionation (black
bars: change from nonfractionated to fractionated U‐AEGM, white
bars: change from fractionated to nonfractionated U‐AEGM) for each
protocol separately, applied to the control (upper panel) and AF
groups (lower panel). In contrast to the control group, the percentage
of fractionation increases with shorter APES (coupling) intervals
in the AF group, for fixed‐rate stimuli as well as for extra stimuli.
Table S2 demonstrates that there is a significant difference in Δ
fractionation between both groups for APES protocols 2 and 5
TABLE 3 Shortest effective stimulation intervalsa
Fixed‐rate burst S1 with extra
stimulus S2 at
Successive
Patient no.
History
of AF
8S1
600, ms
8S1
500, ms
8S1
400, ms
Decremental
burst, ms
1 X 250 250 250 250
2 250 250 250 250
3 350 350 250 250
4 X 350 NA 350 310
5 250 250 250 200
6 X 300 300 300 220
7 300 300 300 250
8 X 350 300 NA NA
9 X 350 350 350 300
10 250 250 250 250
11 X 300 350 300 390
12 X 300 300 300 250
13 250 250 300 200
14 NA 250 250 250
15 X 250 250 250 200
16 250 250 250 250
17 X 350 350 350 300
18 250 250 250 250
19 250 250 250 200
20 300 300 300 250
21 X 300 300 250 NA
22 250 250 250 250
23 250 250 300 200
24 X 250 250 250 200
25 250 250 250 200
26 250 250 250 200
27 300 300 NA 200
28 300 350 NA 200
29 NA 250 250 200
30 NA 300 250 200
Note: The shortest effective stimulated intervals observed during the
application of the APES protocols are displayed. The shortest interval
resulting in atrial capture is given in relation with the details of the
specific APES protocol.
Abbreviations: 8S1, train of 8 fixed rate stimuli at given cycle length; NA,
not available; S2, extra stimulus.
aStimulation protocols were designed with 50ms decreasing steps. Some
decremental burst protocols were executed with −10ms steps (values bold
italic).
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(fixed‐rate stimulation, control vs AF groups; P ≤ .045) and protocols
8, 13, and 14 (extra stimuli, control vs AF groups; P ≤ .014).
3.5 | Impact of decremental stimulation on
U‐AEGM morphology
Compared to the SR beat preceding the decremental stimuli, the
last captured APES beat resulted in a decreased amplitude and an
increased fractionation. These changes differed significantly between
the control and the AF group (amplitude −0.81 [−9.50 to 4.85] vs
−0.25mV [−5.83 to 4.82]; P = .000 and fractionation 34.1% vs 49.3%;
P = .005, respectively). Changes in U‐AEGM width (control group vs AF
group, 0 [−48 to 90] vs −1ms [−42 to 34]; P = .571) were not significant.
3.6 | Optimal APES protocol
The impact of each APES protocol on changes in width, amplitude,
and fractionation is summarized in Table 4. On the basis of sig-
nificances for changes in width, amplitude, and fractionation within
and between the control and the AF groups, the most optimal APES
protocol unraveling local conduction abnormalities, was
protocol 14, which consisted of fixed‐rate stimulation with extra
stimuli (8S1‐S2 = 400‐250ms). Although protocol 7 also showed
F IGURE 3 Stability of SR U‐AEGM widths and amplitudes.
Variation in U‐AEGM widths (upper panel) and amplitude
(lower panel) per each individual electrode no. 1 to 10 are
displayed for patients without and with a history of AF
separately. AF, atrial fibrillation; SR, sinus rhythm; U‐AEGM,
unipolar atrial electrogram
F IGURE 4 Impact of APES protocols on U‐AEGM width and
amplitude. Δ U‐AEGM widths (upper panel) and Δ U‐AEGM
amplitudes (lower panel) for each separate protocol in the control
and AF group. AF, atrial fibrillation; APES, atrial programmed
electrical stimulation; U‐AEGM, unipolar atrial electrogram
F IGURE 5 Impact of APES protocols on U‐AEGM fractionation.
The impact of each different APES protocol on U‐AEGM
fractionation of both the control group (upper panel) and the AF
group (lower panel). Black bars represent the change due to APES
from no fractionation to fractionation (+), white bars represent a
change from fractionation to no fractionation (−). AF, atrial
fibrillation; APES, atrial programmed electrical stimulation; U‐AEGM,
unipolar atrial electrogram
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significant differences between the control group and the AF group,
changes in fractionation, however, were not significant.
4 | DISCUSSION
In this study, we compared the impact of APES techniques on U‐AEGM
morphology between patients without (control group) and with a
history of AF. From our data, it appeared that the most optimal
stimulation protocol for unraveling local conduction abnormalities
reflected by significant U‐AEGM changes in morphology (width,
amplitude, and fractionation) consists of fixed‐rate stimulation at a
drive train of 400ms followed by extra stimuli with a coupling interval
of 250ms. This study is the first step towards examining the value of
APES for the detection of AF‐related conduction disorders.
4.1 | Changes in U‐AEGM morphology related to
stimulation sequence—interval and AF
U‐AEGM morphology during SR did not change over time, demon-
strating stable catheter positions. This enabled us to compare
U‐AEGM morphology changes recorded during APES with the
preceding SR U‐AEGMs.
Electrogram (EGM) width is inversely related to the conduction
velocity (CV). Prior studies demonstrated that slowing of conduction
in the left atrial (LA) precedes the initiation of AF, and this, in turn, is
related to increased AF vulnerability and persistence.18,19 In various
animal models, AR and CV decreased, while AF inducibility and
duration increased, but these results were measured after days of
long‐lasting fixed high‐rate atrial stimulation.20,21 During fixed‐rate
stimulation with extra stimuli, we found an increasing U‐AEGM width
when the coupling interval was shortened. However, we observed an
acute decrease in U‐AEGM width during fixed‐rate APES. The mea-
surements during fixed‐rate APES in this study were taken shortly
(within seconds) after the start of stimulation (S1) (or directly from
the extra stimulus (S2), with only eight preceding S1 beats), and SR
recovered between the different APES protocols. Although adapta-
tion of the action potential duration (APD) to an elevated (stimula-
tion) rate starts immediately after the CL changes, it reaches a new
steady state only after at least 30 seconds.22 The same will apply to
the ECG width. Thus, in this study, measurements were taken during
nonsteady state conditions. Because the AR is correlated to the
APD,23 this, in turn, made it unlikely that the results of this study
could have been influenced by decreased AR rate adaptation due to
prolonged elevated stimulation rates.
In addition, in contrast to the studies mentioned above,
none of the patients in this study had a history of long‐standing
persistent AF, when structural remodeling (with even advanced
slowing of conduction due to increasing anisotropy) has become
more pronounced.
We observed that the U‐AEGM amplitudes in the AF group
during SR and during APES are lower compared to the control group,
and amplitudes decrease with decreasing APES intervals, also
especially in patients with a history of AF.
Lower atrial EGM amplitudes have frequently been observed in
LA voltage maps in patients with AF undergoing endovascular
pulmonary vein isolation procedures.24,25 It is generally assumed that
TABLE 4 Significances in U‐AEGM morphology changes; identification of the most optimal stimulation protocol
Note: Values are bold when P ≤ .50. ┼, significant in all; ─, significant in one or two; 0, significant in none of the parameters. Due to defined binomin al
nature of fractionation, values for AF⊝ and AF⊕ are not available. Significance of the impact of each APES protocol on the U‐AEGM morphology
(including width, amplitude, and fractionation) for the entire study population and for patients without and patients with a history of AF separately. The
right column displays in which protocols overall morphological changes, and changes between patients without and with a history of AF, were significant.
Abbreviations: AF⊝, patients without a history of atrial fibrillation; AF⊕, patients with a history of AF; BCL, basic cycle length; S1, train of fixed‐rate
stimulation at given cycle length; S2, single extra stimulus at given cycle length; SR, sinus rhythm; U‐AEGM, unipolar atrial electrogram.
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decreased EGM amplitudes correlate with advanced fibrosis of atrial
tissue. While most authors used bipolar EGM recording techniques,
this study confirms that amplitudes of unipolar atrial potentials are
also decreased in patients with AF.
In this study, fractionation did not increase in the control group,
while it increased with decreasing APES intervals in the AF group. These
changes occurred during fixed‐rate stimulation, stimulation with extra
stimuli, as well as during decremental stimulation. These findings are
comparable with earlier observations of slowing of conduction and
increasing signal complexity (fractionation) in patients with AF.26,27 In line
with previous studies, we also found an association between decreased
U‐AEGM amplitudes and increased fractionation.19
The results of this study add more insight to how APES affects
the unipolar morphology. This is important, because bipolar record-
ing has its limitations for morphological characterization of tissue
conduction properties.28,29 To the best of our knowledge, no studies
on the influence of electrical stimulation on the unipolar EGM
morphology have been published. Our results showed similar findings
for unipolar EGM amplitude and fractionation. However, we found
that a relation between width and fractionation is less pronounced
than expected from studies based on the bipolar recording. We
suppose that the interaction of both discrete recording pole signals
during bipolar EGM recording is accountable for differences found
between unipolar and bipolar EGM.
In addition, while most studies focussed on the LA,15,18,19,26 the
results of this study show that conduction abnormalities are not limited
to the LA alone, but can also be detected in the right atrial (RA).8,27
We found differences in U‐AEGM morphology during APES
between patients without and with a history of AF. Although this
could be expected, it was not the aim of this study. No further
research into the patient‐specific differences between these groups
was conducted. In this study, the protocol of 8S1‐S2 at 400‐250ms
demonstrated the most significant morphological changes between
both groups. This shows that during acute measurements, at least
a relatively fast APES protocol with an extra stimulus close to AR
(8S1‐S2) is needed to unmask these differences. We assume that
both reduced rate adaptation ability and AR in patients with
(a history of) AF play a major role, and that a marked difference
between S1 and S2 is needed, especially during acute measurements.
However, the effectiveness of APES decreases when S2 approaches
AR, so this can be a limitation of the usefulness of APES for the
detection of AF‐related conduction abnormalities.
4.2 | Study limitations
Occasionally, not all the APES protocols could be applied to all
patients due to unintended induction of AF. We examined only
one stimulation and one recording catheter position. Multisite
high‐resolution recording and stimulation is needed to address
regional and directional influences of APES on U‐AEGM morphol-
ogy.29 The degree of contact of the recording electrodes with
the atrial wall during APES remains uncertain which could have
influenced U‐AEGM morphology, in particular the amplitude.
Nevertheless, our findings on changes in U‐AEGM width, amplitude,
and fractionation during APES were consistent with each other.
5 | CONCLUSION
This electrophysiology study in the RA shows that APES results in
significant changes in U‐AEGM morphology including width,
amplitude, and fractionation, which were more pronounced in
patients with a history of AF. Fixed‐rate stimulation with an extra
stimulus at a relatively fast rate (8S1‐S2 at 400‐250 ms) was the
most optimal APES protocol to reveal morphological changes in
the U‐AEGM. This study supports the concept that dedicated APES
is useful to unmask conduction abnormalities which may be related
to AF; however, further research is necessary to clarify its value
for the individual patient.
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